Status:
COMPLETED
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
Evaluate chemotherapy related tumor markers on non small cell lung cancer by fluorescent in situ hybridization and immunohistochemistry, targets to be studied include EGFR, c-MET, topoisomerase II, p5...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed lung cancer who received standard platinum-containing doublet chemotherapy followed by EGFR tyrosine kinase inhibitors.
Exclusion
- non
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01141686
Start Date
May 1 2009
End Date
December 1 2009
Last Update
June 10 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.